Europe approves use of Pfizer vaccine for children 5 years and over

On Thursday, the European Medicines Regulatory Authority announced the approval of the Pfizer vaccine for children between the ages of 5 and 11 years, paving the way for the start of vaccination for this category in the European Union.

And the European Agency said in a statement that a group of experts "recommended the approval of expanding the use of the Pfizer vaccine against Covid-19 to include its administration to children between 5 and 11 years."

This vaccine is approved for adolescents over 12 years of age in the 27 European Union countries.

Outside of Europe, the Pfizer vaccine has been approved for children aged 5 to 11 years in a handful of countries including the United States, Israel and Canada.

The European regulator said that children aged between 5 and 11 years would get a third of the dose used for the oldest, in two doses separated by three weeks.

She added that the vaccine showed an effectiveness of 90.7% in a trial that included 2,000 children of this age group.

The European Regulatory Authority concluded that the benefits of the Pfizer vaccine for children aged 5 to 11 years outweigh its risks, especially for those who suffer from diseases that severely increase the risk of infection from Covid-19, "

according to a statement.

Follow our latest local and sports news and the latest political and economic developments via Google news